Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors

Á Lahiguera, P Hyroššová, A Figueras… - EMBO molecular …, 2020 - embopress.org
Mitochondrial metabolism and the generation of reactive oxygen species (ROS) contribute to
the acquisition of DNA mutations and genomic instability in cancer. How genomic instability …

Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors.

Á Lahiguera, P Hyroššová, A Figueras… - EMBO molecular …, 2020 - escholarship.org
Mitochondrial metabolism and the generation of reactive oxygen species (ROS) contribute to
the acquisition of DNA mutations and genomic instability in cancer. How genomic instability …

[PDF][PDF] Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors

Á Lahiguera, P Hyroššová, A Figueras, D Garzón… - 2020 - researchgate.net
Mitochondrial metabolism and the generation of reactive oxygen species (ROS) contribute to
the acquisition of DNA mutations and genomic instability in cancer. How genomic instability …

Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors

Á Lahiguera, P Hyrossová… - … Medicine, 2020, p …, 2020 - dipositint.ub.edu
Mitochondrial metabolism and the generation of reactive oxygen species (ROS) contribute to
the acquisition of DNA mutations and genomic instability in cancer. How genomic instability …

Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors.

Á Lahiguera, P Hyroššová, A Figueras… - EMBO Molecular …, 2020 - europepmc.org
Mitochondrial metabolism and the generation of reactive oxygen species (ROS) contribute to
the acquisition of DNA mutations and genomic instability in cancer. How genomic instability …

[HTML][HTML] Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors

Á Lahiguera, P Hyroššová, A Figueras… - EMBO Molecular …, 2020 - ncbi.nlm.nih.gov
Mitochondrial metabolism and the generation of reactive oxygen species (ROS) contribute to
the acquisition of DNA mutations and genomic instability in cancer. How genomic instability …

Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors

Á Lahiguera, P Hyroššová, A Figueras… - EMBO Molecular …, 2020 - search.proquest.com
Mitochondrial metabolism and the generation of reactive oxygen species (ROS) contribute to
the acquisition of DNA mutations and genomic instability in cancer. How genomic instability …

[HTML][HTML] Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors

Á Lahiguera, P Hyroššová, A Figueras… - EMBO Molecular …, 2020 - embopress.org
Mitochondrial metabolism and the generation of reactive oxygen species (ROS) contribute to
the acquisition of DNA mutations and genomic instability in cancer. How genomic instability …

Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors

Á Lahiguera, P Hyroššová… - EMBO molecular …, 2020 - pubmed.ncbi.nlm.nih.gov
Mitochondrial metabolism and the generation of reactive oxygen species (ROS) contribute to
the acquisition of DNA mutations and genomic instability in cancer. How genomic instability …

[PDF][PDF] Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors

Á Lahiguera, P Hyroššová, A Figueras, D Garzón… - 2020 - scholar.archive.org
Mitochondrial metabolism and the generation of reactive oxygen species (ROS) contribute to
the acquisition of DNA mutations and genomic instability in cancer. How genomic instability …